Tag: Acerus Pharmaceuticals

March 4, 2020

Acerus Reports Fourth Quarter and Full Year 2019 Financial Results

Acerus Pharmaceuticals reported its financial results for the three and twelve-month period ended December 31, 2019. 
November 14, 2019

Acerus Pharmaceuticals Reports Q3 Financial Results

The company announced in its results that it is preparing to launch its NATESTO in the United States in partnership...
November 1, 2019

Acerus Updates on Temporary Unavailability of NATESTO in Canada and South Korea

This comes following a previous announcement of the voluntary replacement of certain NATESTO lots available in Canada and South Korea...
July 19, 2019

Acerus Announces Closing of US$5 Million Secured Term Loan

Acerus Pharmaceuticals (TSX:ASP, OTCQB:ASPCF) has announced it has entered into a US$5 million subordinated secured term loan facility with First...
June 6, 2019

VIDEO — US vs. Canada Healthcare Systems: Is One Better?

INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...
May 16, 2019

VIDEO Round-Up BBHIC 2019

BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...
May 10, 2019

VIDEO — Acerus Pharma CEO: Keeping Focus on Drug Delivery Tech, Not Cannabis

In this BBHIC interview, Acerus Pharmaceuticals CEO Ed Gudaitis explains why the company isn't directly pursuing the cannabis market.